| Year |
Citation |
Score |
| 2020 |
Huh YE, Ruby Chiang MS, Locascio JJ, Liao Z, Liu G, Choudhury K, Kuras YI, Tuncali I, Videnovic A, Hunt AL, Schwarzschild MA, Hung AY, Herrington TM, Hayes MT, Hyman BT, ... Wills AM, et al. β-Glucocerebrosidase Activity in -linked Parkinson's Disease: The Type of Mutation Matters. Neurology. PMID 32540937 DOI: 10.1212/Wnl.0000000000009989 |
0.365 |
|
| 2020 |
Bakshi R, Macklin EA, Hung AY, Hayes MT, Hyman BT, Wills AM, Gomperts SN, Growdon JH, Ascherio A, Scherzer CR, Schwarzschild MA. Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study. Journal of Parkinson's Disease. 10: 505-510. PMID 32250320 DOI: 10.3233/Jpd-191882 |
0.43 |
|
| 2020 |
Rotunno MS, Lane M, Zhang W, Wolf P, Oliva P, Viel C, Wills AM, Alcalay RN, Scherzer CR, Shihabuddin LS, Zhang K, Sardi SP. Cerebrospinal fluid proteomics implicates the granin family in Parkinson's disease. Scientific Reports. 10: 2479. PMID 32051502 DOI: 10.1038/S41598-020-59414-4 |
0.38 |
|
| 2020 |
Peterschmitt MJ, Saiki H, Hatano T, Gasser T, Isaacson S, Kulisevsky J, Simuni T, Takahashi Y, Wills A, Guedes LC, Svenningsson P, Takahashi R, Waters C, Katsuno M, Ji AJ, et al. Safety, pharmacokinetics, and pharmacodynamics of oral venglustat in Parkinson disease patients with a GBA mutation from Japan and the rest of the world: Results from part 1 of the MOVES-PD study Molecular Genetics and Metabolism. 129: S128. DOI: 10.1016/J.Ymgme.2019.11.334 |
0.44 |
|
| 2019 |
Alcalay RN, Kehoe C, Shorr E, Battista R, Hall A, Simuni T, Marder K, Wills AM, Naito A, Beck JC, Schwarzschild MA, Nance M. Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 31680121 DOI: 10.1038/S41436-019-0684-X |
0.376 |
|
| 2019 |
Mezoian T, Belt E, Garry J, Hubbard J, Breen CT, Miller L, Levine-Weinberg M, Nalipinski P, Sullivan S, Chan J, Wills AM. Loss of Appetite in ALS is Associated with Weight Loss and Decreased Calorie Consumption Independent of Dysphagia. Muscle & Nerve. PMID 31650547 DOI: 10.1002/Mus.26749 |
0.304 |
|
| 2019 |
Wills AM, Garry J, Hubbard J, Mezoian T, Breen CT, Ortiz-Miller C, Nalipinski P, Sullivan S, Berry JD, Cudkowicz M, Paganoni S, Chan J, Macklin EA. Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALS. Bmc Neurology. 19: 104. PMID 31142272 DOI: 10.1186/S12883-019-1330-6 |
0.321 |
|
| 2019 |
Judith Peterschmitt M, Gasser T, Isaacson S, Kulisevsky J, Mir P, Simuni T, Wills A, Guedes LC, Svenningsson P, Waters C, Ji AJ, Li J, Minini P, Nembo B, Saubadu S, et al. Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson disease patients with a GBA mutation Molecular Genetics and Metabolism. 126: S117. DOI: 10.1016/J.Ymgme.2018.12.298 |
0.421 |
|
| 2018 |
Nicholson K, Chan J, Macklin EA, Levine-Weinberg M, Breen C, Bakshi R, Grasso DL, Wills AM, Jahandideh S, Taylor AA, Beaulieu D, Ennist DL, Andronesi O, Ratai EM, Schwarzschild MA, et al. Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology. 5: 1522-1533. PMID 30564619 DOI: 10.1002/Acn3.671 |
0.334 |
|
| 2017 |
Wills AM, Li R, Pérez A, Ren X, Boyd J. Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohort. Journal of Neurology. PMID 28712000 DOI: 10.1007/S00415-017-8562-4 |
0.437 |
|
| 2017 |
Chou KL, Elm JJ, Wielinski CL, Simon DK, Aminoff MJ, Christine CW, Liang GS, Hauser RA, Sudarsky L, Umeh CC, Voss T, Juncos J, Fang JY, Boyd JT, Bodis-Wollner I, ... ... Wills AM, et al. Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort. Journal of the Neurological Sciences. 377: 137-143. PMID 28477684 DOI: 10.1016/J.Jns.2017.04.011 |
0.435 |
|
| 2017 |
Simon DK, Wu C, Tilley BC, Lohmann K, Klein C, Payami H, Wills AM, Aminoff MJ, Bainbridge J, Dewey R, Hauser RA, Schaake S, Schneider JS, Sharma S, Singer C, et al. Caffeine, creatine, GRIN2A and Parkinson's disease progression. Journal of the Neurological Sciences. 375: 355-359. PMID 28320167 DOI: 10.1016/J.Jns.2017.02.032 |
0.432 |
|
| 2017 |
Paganoni S, Macklin EA, Karam C, Yu H, Gonterman F, Fetterman KA, Cudkowicz M, Berry J, Wills AM. Vitamin D levels are associated with gross motor function in ALS. Muscle & Nerve. PMID 28044349 DOI: 10.1002/Mus.25555 |
0.313 |
|
| 2016 |
Wills AM, Boyd J, Pérez A. Association Between Body Mass Index and Parkinson Disease-Reply. Jama Neurology. PMID 27214659 DOI: 10.1001/Jamaneurol.2016.1245 |
0.346 |
|
| 2015 |
Simon DK, Wu C, Tilley BC, Wills AM, Aminoff MJ, Bainbridge J, Hauser RA, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wong PS. Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine. Clinical Neuropharmacology. 38: 163-9. PMID 26366971 DOI: 10.1097/Wnf.0000000000000102 |
0.447 |
|
| 2015 |
Locascio JJ, Eberly S, Liao Z, Liu G, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Dhima K, Hung AY, Flaherty AW, Schwarzschild MA, Hayes MT, Wills AM, Shivraj Sohur U, Mejia NI, et al. Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease. Brain : a Journal of Neurology. 138: 2659-71. PMID 26220939 DOI: 10.1093/Brain/Awv202 |
0.39 |
|
| 2015 |
Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, Augustine AH, Augustine EU, Aminoff MJ, Bodis-Wollner IG, Boyd J, Cambi F, Chou K, Christine CW, ... ... Wills AM, et al. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. Jama. 313: 584-93. PMID 25668262 DOI: 10.1001/Jama.2015.120 |
0.371 |
|
| 2014 |
Wills AM, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, Brooks B, Gelinas D, Mitsumoto H, Mozaffar T, Hanes GP, Ladha SS, Heiman-Patterson T, Katz J, Lou JS, et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet (London, England). 383: 2065-72. PMID 24582471 DOI: 10.1016/S0140-6736(14)60222-1 |
0.378 |
|
| 2013 |
Zhang M, Hubbard J, Rudnicki SA, Johansen CS, Dalton K, Heiman-Patterson T, Forshew DA, Wills AM. Survey of current enteral nutrition practices in treatment of amyotrophic lateral sclerosis. E-Spen Journal. 8: e25-e28. PMID 25568837 DOI: 10.1016/J.Clnme.2012.11.003 |
0.316 |
|
| 2013 |
Ding H, Dhima K, Lockhart KC, Locascio JJ, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Hayes MT, Sohur US, Wills AM, Mollenhauer B, Flaherty AW, Hung AY, Mejia N, Khurana V, et al. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology. 81: 1531-7. PMID 24068787 DOI: 10.1212/Wnl.0B013E3182A95818 |
0.379 |
|
| 2013 |
Paganoni S, Wills AM. High-fat and ketogenic diets in amyotrophic lateral sclerosis. Journal of Child Neurology. 28: 989-92. PMID 23666040 DOI: 10.1177/0883073813488669 |
0.345 |
|
| 2012 |
Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. What does body mass index measure in amyotrophic lateral sclerosis and why should we care? Muscle & Nerve. 45: 612. PMID 22431098 DOI: 10.1002/Mus.22338 |
0.327 |
|
| 2012 |
Paganoni S, Zhang M, Quiroz Zárate A, Jaffa M, Yu H, Cudkowicz ME, Wills AM. Uric acid levels predict survival in men with amyotrophic lateral sclerosis. Journal of Neurology. 259: 1923-8. PMID 22323210 DOI: 10.1007/S00415-012-6440-7 |
0.348 |
|
| 2011 |
van Es MA, Schelhaas HJ, van Vught PW, Ticozzi N, Andersen PM, Groen EJ, Schulte C, Blauw HM, Koppers M, Diekstra FP, Fumoto K, LeClerc AL, Keagle P, Bloem BR, Scheffer H, ... ... Wills AM, et al. Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Annals of Neurology. 70: 964-73. PMID 22190368 DOI: 10.1002/Ana.22611 |
0.475 |
|
| 2011 |
Ding H, Sarokhan AK, Roderick SS, Bakshi R, Maher NE, Ashourian P, Kan CG, Chang S, Santarlasci A, Swords KE, Ravina BM, Hayes MT, Sohur US, Wills AM, Flaherty AW, et al. Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2283-6. PMID 21953863 DOI: 10.1002/Mds.23934 |
0.418 |
|
| 2011 |
Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle & Nerve. 44: 20-4. PMID 21607987 DOI: 10.1002/Mus.22114 |
0.351 |
|
| 2011 |
Ticozzi N, LeClerc AL, van Blitterswijk M, Keagle P, McKenna-Yasek DM, Sapp PC, Silani V, Wills AM, Brown RH, Landers JE. Mutational analysis of TARDBP in neurodegenerative diseases. Neurobiology of Aging. 32: 2096-9. PMID 20031275 DOI: 10.1016/J.Neurobiolaging.2009.11.018 |
0.422 |
|
| 2009 |
Landers JE, Melki J, Meininger V, Glass JD, van den Berg LH, van Es MA, Sapp PC, van Vught PW, McKenna-Yasek DM, Blauw HM, Cho TJ, Polak M, Shi L, Wills AM, Broom WJ, et al. Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 106: 9004-9. PMID 19451621 DOI: 10.1073/Pnas.0812937106 |
0.321 |
|
| 2005 |
Wills AM, Plante DT, Dukkipati SR, Corcoran CP, Standaert DG. Pacemaker-induced tachycardia caused by inappropriate response to parkinsonian tremor. Neurology. 65: 1676-7. PMID 16301511 DOI: 10.1212/01.wnl.0000184489.74795.b2 |
0.492 |
|
| Show low-probability matches. |